EUVIMEDEUVIMED entdecken
Crossref

Metabolism of omegas 3: Which is responsible for cardioprotective effects?

J. Roy, C. Oger, J. Fauconnier, C. Farah, J. Lee, V. Bultel Ponce, C. Vigor, A. Lacampagne, J.M. Galano, T. Durand, J.Y. Le Guennec

Archives of Cardiovascular Diseases Supplements · 2018-04 · 10 (2) · 230-231

DOI: 10.1016/j.acvdsp.2018.02.119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Cardiovascular Diseases Supplements, 2018-04. Verfasst von J. Roy und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Roy, J., Oger, C., Fauconnier, J., Farah, C., Lee, J., Ponce, V. B., Vigor, C., Lacampagne, A., Galano, J., Durand, T., & Guennec, J. L. (2018). Metabolism of omegas 3: Which is responsible for cardioprotective effects?. Archives of Cardiovascular Diseases Supplements, 10(2), 230-231. https://doi.org/10.1016/j.acvdsp.2018.02.119

Vancouver

Roy J, Oger C, Fauconnier J, Farah C, Lee J, Ponce VB, et al. Metabolism of omegas 3: Which is responsible for cardioprotective effects?. Archives of Cardiovascular Diseases Supplements. 2018;10(2):230-231. doi:10.1016/j.acvdsp.2018.02.119

BibTeX
@article{Roy2018,
  author = {Roy, J. and Oger, C. and Fauconnier, J. and Farah, C. and Lee, J. and Ponce, V. Bultel and Vigor, C. and Lacampagne, A. and Galano, J.M. and Durand, T. and Guennec, J.Y. Le},
  title = {Metabolism of omegas 3: Which is responsible for cardioprotective effects?},
  journal = {Archives of Cardiovascular Diseases Supplements},
  year = {2018},
  volume = {10},
  number = {2},
  pages = {230--231},
  doi = {10.1016/j.acvdsp.2018.02.119}
}
Kostenlos starten →